Napatra Tovanabutra

695 total citations
39 papers, 445 citations indexed

About

Napatra Tovanabutra is a scholar working on Rheumatology, Epidemiology and Pharmacology. According to data from OpenAlex, Napatra Tovanabutra has authored 39 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Rheumatology, 13 papers in Epidemiology and 12 papers in Pharmacology. Recurrent topics in Napatra Tovanabutra's work include Urticaria and Related Conditions (13 papers), Drug-Induced Adverse Reactions (11 papers) and Autoimmune Bullous Skin Diseases (8 papers). Napatra Tovanabutra is often cited by papers focused on Urticaria and Related Conditions (13 papers), Drug-Induced Adverse Reactions (11 papers) and Autoimmune Bullous Skin Diseases (8 papers). Napatra Tovanabutra collaborates with scholars based in Thailand, United States and United Kingdom. Napatra Tovanabutra's co-authors include Siri Chiewchanvit, Mati Chuamanochan, Leena Chularojanamontri, Pawinee Rerknimitr, Chonlaphat Sukasem, Jettanong Klaewsongkram, Papapit Tuchinda, Ticha Rerkpattanapipat, Surapon Nochaiwong and Aimee Payne and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Frontiers in Immunology and Molecules.

In The Last Decade

Napatra Tovanabutra

36 papers receiving 438 citations

Peers

Napatra Tovanabutra
Baptiste Janela Singapore
Napatra Tovanabutra
Citations per year, relative to Napatra Tovanabutra Napatra Tovanabutra (= 1×) peers Baptiste Janela

Countries citing papers authored by Napatra Tovanabutra

Since Specialization
Citations

This map shows the geographic impact of Napatra Tovanabutra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Napatra Tovanabutra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Napatra Tovanabutra more than expected).

Fields of papers citing papers by Napatra Tovanabutra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Napatra Tovanabutra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Napatra Tovanabutra. The network helps show where Napatra Tovanabutra may publish in the future.

Co-authorship network of co-authors of Napatra Tovanabutra

This figure shows the co-authorship network connecting the top 25 collaborators of Napatra Tovanabutra. A scholar is included among the top collaborators of Napatra Tovanabutra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Napatra Tovanabutra. Napatra Tovanabutra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takuathung, Mingkwan Na, et al.. (2025). Therapeutic Potential of Curcumin and Novel Formulations in Psoriasis Treatment: Evidence and Future Prospects. Drug Design Development and Therapy. Volume 19. 5387–5414. 2 indexed citations
2.
Chuamanochan, Mati, et al.. (2025). Chilblain-like lesion associated with coronavirus disease 2019 vaccine in tropical country: a case report. Journal of Medical Case Reports. 19(1). 213–213.
3.
Satapornpong, Patompong, Thawinee Jantararoungtong, Napatrupron Koomdee, et al.. (2024). Influence of pharmacogenomic polymorphisms on allopurinol-induced cutaneous adverse drug reactions in Thai patients. BMC Medical Genomics. 17(1). 101–101. 1 indexed citations
4.
Piccolo, Luca Lo, Timothy E. O’Brien, Suteeraporn Chaowattanapanit, et al.. (2024). Human Leukocyte Antigen Markers for Distinguishing Pustular Psoriasis and Adult-Onset Immunodeficiency with Pustular Reaction. Genes. 15(3). 278–278. 1 indexed citations
5.
Chieosilapatham, Panjit, Romanee Chaiwarith, Phichayut Phinyo, et al.. (2024). Comparative immunohistochemical analysis of inflammatory cytokines in distinct subtypes of Sweet syndrome. Frontiers in Immunology. 15. 1355681–1355681. 2 indexed citations
6.
Chongpison, Yuda, Sira Sriswasdi, Supranee Buranapraditkun, et al.. (2023). IFN-γ ELISpot-enabled machine learning for culprit drug identification in nonimmediate drug hypersensitivity. Journal of Allergy and Clinical Immunology. 153(1). 193–202. 6 indexed citations
7.
Leeyaphan, Charussri, Chatree Chai‐Adisaksopha, Napatra Tovanabutra, Phichayut Phinyo, & Sumanas Bunyaratavej. (2023). Prognostic factors for mycological cure in patients with onychomycosis caused by Neoscytalidium dimidiatum: A retrospective cohort study. Mycoses. 66(6). 497–504. 4 indexed citations
8.
Leeyaphan, Charussri, Chatree Chai‐Adisaksopha, Napatra Tovanabutra, Phichayut Phinyo, & Sumanas Bunyaratavej. (2023). Developing diagnostic criteria to differentiate fungal foot infections caused by Neoscytalidium dimidiatum and dermatophytes. Heliyon. 9(8). e18963–e18963. 2 indexed citations
9.
Phinyo, Phichayut, et al.. (2023). Reactive Neutrophilic Dermatoses in Adult-Onset Immunodeficiency due to Interferon-Gamma Autoantibody and Their Associated Factors. Dermatology. 239(2). 248–254. 3 indexed citations
10.
Chaiwarith, Romanee, et al.. (2022). Ulcerated Nodule in Patient with Talaromycosis: Re-visit a Neglected Disease in the Era of Antiretroviral Therapy. International Journal of Infectious Diseases. 122. 81–82.
11.
Tovanabutra, Napatra, et al.. (2021). Temporal Outcomes after Rituximab Therapy for Pemphigus Vulgaris. Journal of Investigative Dermatology. 142(4). 1058–1064.e7. 9 indexed citations
12.
Nochaiwong, Surapon, Mati Chuamanochan, Chidchanok Ruengorn, et al.. (2021). Impact of Pharmacological Treatments for Chronic Spontaneous Urticaria with an Inadequate Response to H1-Antihistamines on Health-Related Quality of Life: A Systematic Review and Network Meta-Analysis. The Journal of Allergy and Clinical Immunology In Practice. 10(1). 297–308. 13 indexed citations
13.
Anuchapreeda, Songyot, et al.. (2020). Nanomaterial Lipid-Based Carrier for Non-Invasive Capsaicin Delivery; Manufacturing Scale-Up and Human Irritation Assessment. Molecules. 25(23). 5575–5575. 14 indexed citations
14.
Phinyo, Phichayut, et al.. (2020). Comparative Efficacy and Acceptability of Licensed Dose Second-Generation Antihistamines in Chronic Spontaneous Urticaria: A Network Meta-Analysis. The Journal of Allergy and Clinical Immunology In Practice. 9(2). 956–970.e57. 24 indexed citations
15.
Chuamanochan, Mati, et al.. (2019). A case of dengue fever presenting with acute urticaria. Asian Pacific Journal of Allergy and Immunology. 40(1). 72–74. 4 indexed citations
17.
Srinoulprasert, Yuttana, Pattarawat Thantiworasit, Pawinee Rerknimitr, et al.. (2018). The measurement of drug‐induced interferon γ‐releasing cells and lymphocyte proliferation in severe cutaneous adverse reactions. Journal of the European Academy of Dermatology and Venereology. 32(6). 992–998. 33 indexed citations
18.
Sukasem, Chonlaphat, Patompong Satapornpong, Kanoot Jaruthamsophon, et al.. (2018). Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients. Journal of Immunology Research. 2018. 1–11. 56 indexed citations
19.
Klaewsongkram, Jettanong, Chonlaphat Sukasem, Pattarawat Thantiworasit, et al.. (2018). Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs. The Journal of Allergy and Clinical Immunology In Practice. 7(1). 219–227.e4. 32 indexed citations
20.
Tovanabutra, Napatra, et al.. (2013). Pentoxifylline as add-on therapy in the treatment of moderate to severe psoriasis. 52. 43–50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026